1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Cardiac Tamponade in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Smail, N; Spapen, H; Verhaeghe, V; Vincent, JL; Zhang, H | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cardiac Tamponade
Article | Year |
---|---|
The platelet-activating factor antagonist BB-882 does not improve tissue oxygen extraction in endotoxic shock.
Topics: Animals; Cardiac Output; Cardiac Tamponade; Dogs; Endotoxins; Escherichia coli; Female; Hemodynamics; Leucine; Male; Myocardial Contraction; Oxygen; Oxygen Consumption; Platelet Activating Factor; Pulmonary Wedge Pressure; Shock, Septic | 1998 |